PD-L1 and PIK3CA Testing Industry Research Report 2023
PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to 'trick' the immune system, and avoid being attacked as foreign, harmful substances.
Current PD-L1 testing is based on immunohistochemistry (IHC) methods. Immunohistochemistry (IHC) is the process whereby antibodies are used to detect proteins (antigens) in cells within a tissue section (for instance liver, pancreas or the heart).
PD-L1 is a ligand that binds to PD-1 (programmed cell death-1), expressed on activated T cells, to evade anti-tumor responses. PD-L1 plays a role in inhibiting T cell activation and proliferation and has emerged as an important target in cancer treatment. PD-L1 protein detection by immunohistochemistry (IHC) testing is widely used as a predictive biomarker assay for anti–PD-1/PD-L1 therapies.
PIK3CA is a gene that encodes a lipid kinase involved in multiple signaling pathways. These pathways influence cellular functions such as growth, death, and proliferation. PIK3CA mutations activate the PI3K-PTEN-AKT pathway, which is downstream from both the EGFR and the RAS-RAF-MAPK pathways. PIK3CA mutations may cause oncogenic transformation independent of RAS or RAF mutations.
PIK3CA mutations occur in about 15% to 30% of breast, endometrial, and colon cancers. They occur less frequently in lung cancer and other types of cancer. Presence of PIK3CA mutations is associated with poor prognosis and lack of response to specific therapies in patients with breast, endometrial, or colon cancer.
Highlights
The global PD-L1 and PIK3CA Testing market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
The classification of PD-L1 and PIK3CA Testing Product includes PD-L1 Testing and PIK3CA Testing. PD-L1 accounted for a share of 80% in the global PD-L1 and PIK3CA Testing Product market.
PD-L1 and PIK3CA Testing Product is widely used in Hospital, Diagnostic Center and Other. In PD-L1 and PIK3CA Testing Product market, the Diagnostic Center holds an important share in terms of Application.
North America is the largest consumption place, with a market share nearly 57% . Following North America, Europe is the second largest consumption place with the market share of 28%.
Market competition is intense. Agilent Technologies, Roche, QIAGEN, Amoy Diagnostics, ACCB Biotech, etc. The top five vendors held 84% of the market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for PD-L1 and PIK3CA Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PD-L1 and PIK3CA Testing.
The PD-L1 and PIK3CA Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global PD-L1 and PIK3CA Testing market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PD-L1 and PIK3CA Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by PD-L1 and PIK3CA Testing type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the PD-L1 and PIK3CA Testing are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
PD-L1 and PIK3CA Testing segment by Type
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the PD-L1 and PIK3CA Testing market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the PD-L1 and PIK3CA Testing market.
PD-L1 and PIK3CA Testing Segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the PD-L1 and PIK3CA Testing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PD-L1 and PIK3CA Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of PD-L1 and PIK3CA Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the PD-L1 and PIK3CA Testing industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PD-L1 and PIK3CA Testing.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of PD-L1 and PIK3CA Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Current PD-L1 testing is based on immunohistochemistry (IHC) methods. Immunohistochemistry (IHC) is the process whereby antibodies are used to detect proteins (antigens) in cells within a tissue section (for instance liver, pancreas or the heart).
PD-L1 is a ligand that binds to PD-1 (programmed cell death-1), expressed on activated T cells, to evade anti-tumor responses. PD-L1 plays a role in inhibiting T cell activation and proliferation and has emerged as an important target in cancer treatment. PD-L1 protein detection by immunohistochemistry (IHC) testing is widely used as a predictive biomarker assay for anti–PD-1/PD-L1 therapies.
PIK3CA is a gene that encodes a lipid kinase involved in multiple signaling pathways. These pathways influence cellular functions such as growth, death, and proliferation. PIK3CA mutations activate the PI3K-PTEN-AKT pathway, which is downstream from both the EGFR and the RAS-RAF-MAPK pathways. PIK3CA mutations may cause oncogenic transformation independent of RAS or RAF mutations.
PIK3CA mutations occur in about 15% to 30% of breast, endometrial, and colon cancers. They occur less frequently in lung cancer and other types of cancer. Presence of PIK3CA mutations is associated with poor prognosis and lack of response to specific therapies in patients with breast, endometrial, or colon cancer.
Highlights
The global PD-L1 and PIK3CA Testing market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
The classification of PD-L1 and PIK3CA Testing Product includes PD-L1 Testing and PIK3CA Testing. PD-L1 accounted for a share of 80% in the global PD-L1 and PIK3CA Testing Product market.
PD-L1 and PIK3CA Testing Product is widely used in Hospital, Diagnostic Center and Other. In PD-L1 and PIK3CA Testing Product market, the Diagnostic Center holds an important share in terms of Application.
North America is the largest consumption place, with a market share nearly 57% . Following North America, Europe is the second largest consumption place with the market share of 28%.
Market competition is intense. Agilent Technologies, Roche, QIAGEN, Amoy Diagnostics, ACCB Biotech, etc. The top five vendors held 84% of the market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for PD-L1 and PIK3CA Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PD-L1 and PIK3CA Testing.
The PD-L1 and PIK3CA Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global PD-L1 and PIK3CA Testing market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PD-L1 and PIK3CA Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Agilent Technologies
- Roche
- QIAGEN
- EntroGen
- Amoy Diagnostics
- ACCB Biotech
Global markets are presented by PD-L1 and PIK3CA Testing type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the PD-L1 and PIK3CA Testing are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
PD-L1 and PIK3CA Testing segment by Type
- PD-L1 Testing
- PIK3CA Testing
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the PD-L1 and PIK3CA Testing market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the PD-L1 and PIK3CA Testing market.
PD-L1 and PIK3CA Testing Segment by Application
- Hospital
- Diagnostic Center
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the PD-L1 and PIK3CA Testing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PD-L1 and PIK3CA Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of PD-L1 and PIK3CA Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the PD-L1 and PIK3CA Testing industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PD-L1 and PIK3CA Testing.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of PD-L1 and PIK3CA Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 PD-L1 and PIK3CA Testing by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 PD-L1 Testing
1.2.3 PIK3CA Testing
2.3 PD-L1 and PIK3CA Testing by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Hospital
2.3.3 Diagnostic Center
2.3.4 Others
2.4 Assumptions and Limitations
3 PD-L1 AND PIK3CA TESTING BREAKDOWN DATA BY TYPE
3.1 Global PD-L1 and PIK3CA Testing Historic Market Size by Type (2018-2023)
3.2 Global PD-L1 and PIK3CA Testing Forecasted Market Size by Type (2023-2028)
4 PD-L1 AND PIK3CA TESTING BREAKDOWN DATA BY APPLICATION
4.1 Global PD-L1 and PIK3CA Testing Historic Market Size by Application (2018-2023)
4.2 Global PD-L1 and PIK3CA Testing Forecasted Market Size by Application (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global PD-L1 and PIK3CA Testing Market Perspective (2018-2029)
5.2 Global PD-L1 and PIK3CA Testing Growth Trends by Region
5.2.1 Global PD-L1 and PIK3CA Testing Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 PD-L1 and PIK3CA Testing Historic Market Size by Region (2018-2023)
5.2.3 PD-L1 and PIK3CA Testing Forecasted Market Size by Region (2024-2029)
5.3 PD-L1 and PIK3CA Testing Market Dynamics
5.3.1 PD-L1 and PIK3CA Testing Industry Trends
5.3.2 PD-L1 and PIK3CA Testing Market Drivers
5.3.3 PD-L1 and PIK3CA Testing Market Challenges
5.3.4 PD-L1 and PIK3CA Testing Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top PD-L1 and PIK3CA Testing Players by Revenue
6.1.1 Global Top PD-L1 and PIK3CA Testing Players by Revenue (2018-2023)
6.1.2 Global PD-L1 and PIK3CA Testing Revenue Market Share by Players (2018-2023)
6.2 Global PD-L1 and PIK3CA Testing Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of PD-L1 and PIK3CA Testing Head office and Area Served
6.4 Global PD-L1 and PIK3CA Testing Players, Product Type & Application
6.5 Global PD-L1 and PIK3CA Testing Players, Date of Enter into This Industry
6.6 Global PD-L1 and PIK3CA Testing Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America PD-L1 and PIK3CA Testing Market Size (2018-2029)
7.2 North America PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America PD-L1 and PIK3CA Testing Market Size by Country (2018-2023)
7.4 North America PD-L1 and PIK3CA Testing Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe PD-L1 and PIK3CA Testing Market Size (2018-2029)
8.2 Europe PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe PD-L1 and PIK3CA Testing Market Size by Country (2018-2023)
8.4 Europe PD-L1 and PIK3CA Testing Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific PD-L1 and PIK3CA Testing Market Size (2018-2029)
9.2 Asia-Pacific PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Country (2018-2023)
9.4 Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America PD-L1 and PIK3CA Testing Market Size (2018-2029)
10.2 Latin America PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America PD-L1 and PIK3CA Testing Market Size by Country (2018-2023)
10.4 Latin America PD-L1 and PIK3CA Testing Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa PD-L1 and PIK3CA Testing Market Size (2018-2029)
11.2 Middle East & Africa PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country (2018-2023)
11.4 Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Detail
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies PD-L1 and PIK3CA Testing Introduction
11.1.4 Agilent Technologies Revenue in PD-L1 and PIK3CA Testing Business (2017-2022)
11.1.5 Agilent Technologies Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche PD-L1 and PIK3CA Testing Introduction
11.2.4 Roche Revenue in PD-L1 and PIK3CA Testing Business (2017-2022)
11.2.5 Roche Recent Development
11.3 QIAGEN
11.3.1 QIAGEN Company Detail
11.3.2 QIAGEN Business Overview
11.3.3 QIAGEN PD-L1 and PIK3CA Testing Introduction
11.3.4 QIAGEN Revenue in PD-L1 and PIK3CA Testing Business (2017-2022)
11.3.5 QIAGEN Recent Development
11.4 EntroGen
11.4.1 EntroGen Company Detail
11.4.2 EntroGen Business Overview
11.4.3 EntroGen PD-L1 and PIK3CA Testing Introduction
11.4.4 EntroGen Revenue in PD-L1 and PIK3CA Testing Business (2017-2022)
11.4.5 EntroGen Recent Development
11.5 Amoy Diagnostics
11.5.1 Amoy Diagnostics Company Detail
11.5.2 Amoy Diagnostics Business Overview
11.5.3 Amoy Diagnostics PD-L1 and PIK3CA Testing Introduction
11.5.4 Amoy Diagnostics Revenue in PD-L1 and PIK3CA Testing Business (2017-2022)
11.5.5 Amoy Diagnostics Recent Development
11.6 ACCB Biotech
11.6.1 ACCB Biotech Company Detail
11.6.2 ACCB Biotech Business Overview
11.6.3 ACCB Biotech PD-L1 and PIK3CA Testing Introduction
11.6.4 ACCB Biotech Revenue in PD-L1 and PIK3CA Testing Business (2017-2022)
11.6.5 ACCB Biotech Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 PD-L1 and PIK3CA Testing by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 PD-L1 Testing
1.2.3 PIK3CA Testing
2.3 PD-L1 and PIK3CA Testing by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Hospital
2.3.3 Diagnostic Center
2.3.4 Others
2.4 Assumptions and Limitations
3 PD-L1 AND PIK3CA TESTING BREAKDOWN DATA BY TYPE
3.1 Global PD-L1 and PIK3CA Testing Historic Market Size by Type (2018-2023)
3.2 Global PD-L1 and PIK3CA Testing Forecasted Market Size by Type (2023-2028)
4 PD-L1 AND PIK3CA TESTING BREAKDOWN DATA BY APPLICATION
4.1 Global PD-L1 and PIK3CA Testing Historic Market Size by Application (2018-2023)
4.2 Global PD-L1 and PIK3CA Testing Forecasted Market Size by Application (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global PD-L1 and PIK3CA Testing Market Perspective (2018-2029)
5.2 Global PD-L1 and PIK3CA Testing Growth Trends by Region
5.2.1 Global PD-L1 and PIK3CA Testing Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 PD-L1 and PIK3CA Testing Historic Market Size by Region (2018-2023)
5.2.3 PD-L1 and PIK3CA Testing Forecasted Market Size by Region (2024-2029)
5.3 PD-L1 and PIK3CA Testing Market Dynamics
5.3.1 PD-L1 and PIK3CA Testing Industry Trends
5.3.2 PD-L1 and PIK3CA Testing Market Drivers
5.3.3 PD-L1 and PIK3CA Testing Market Challenges
5.3.4 PD-L1 and PIK3CA Testing Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top PD-L1 and PIK3CA Testing Players by Revenue
6.1.1 Global Top PD-L1 and PIK3CA Testing Players by Revenue (2018-2023)
6.1.2 Global PD-L1 and PIK3CA Testing Revenue Market Share by Players (2018-2023)
6.2 Global PD-L1 and PIK3CA Testing Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of PD-L1 and PIK3CA Testing Head office and Area Served
6.4 Global PD-L1 and PIK3CA Testing Players, Product Type & Application
6.5 Global PD-L1 and PIK3CA Testing Players, Date of Enter into This Industry
6.6 Global PD-L1 and PIK3CA Testing Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America PD-L1 and PIK3CA Testing Market Size (2018-2029)
7.2 North America PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America PD-L1 and PIK3CA Testing Market Size by Country (2018-2023)
7.4 North America PD-L1 and PIK3CA Testing Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe PD-L1 and PIK3CA Testing Market Size (2018-2029)
8.2 Europe PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe PD-L1 and PIK3CA Testing Market Size by Country (2018-2023)
8.4 Europe PD-L1 and PIK3CA Testing Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific PD-L1 and PIK3CA Testing Market Size (2018-2029)
9.2 Asia-Pacific PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Country (2018-2023)
9.4 Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America PD-L1 and PIK3CA Testing Market Size (2018-2029)
10.2 Latin America PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America PD-L1 and PIK3CA Testing Market Size by Country (2018-2023)
10.4 Latin America PD-L1 and PIK3CA Testing Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa PD-L1 and PIK3CA Testing Market Size (2018-2029)
11.2 Middle East & Africa PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country (2018-2023)
11.4 Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Detail
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies PD-L1 and PIK3CA Testing Introduction
11.1.4 Agilent Technologies Revenue in PD-L1 and PIK3CA Testing Business (2017-2022)
11.1.5 Agilent Technologies Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche PD-L1 and PIK3CA Testing Introduction
11.2.4 Roche Revenue in PD-L1 and PIK3CA Testing Business (2017-2022)
11.2.5 Roche Recent Development
11.3 QIAGEN
11.3.1 QIAGEN Company Detail
11.3.2 QIAGEN Business Overview
11.3.3 QIAGEN PD-L1 and PIK3CA Testing Introduction
11.3.4 QIAGEN Revenue in PD-L1 and PIK3CA Testing Business (2017-2022)
11.3.5 QIAGEN Recent Development
11.4 EntroGen
11.4.1 EntroGen Company Detail
11.4.2 EntroGen Business Overview
11.4.3 EntroGen PD-L1 and PIK3CA Testing Introduction
11.4.4 EntroGen Revenue in PD-L1 and PIK3CA Testing Business (2017-2022)
11.4.5 EntroGen Recent Development
11.5 Amoy Diagnostics
11.5.1 Amoy Diagnostics Company Detail
11.5.2 Amoy Diagnostics Business Overview
11.5.3 Amoy Diagnostics PD-L1 and PIK3CA Testing Introduction
11.5.4 Amoy Diagnostics Revenue in PD-L1 and PIK3CA Testing Business (2017-2022)
11.5.5 Amoy Diagnostics Recent Development
11.6 ACCB Biotech
11.6.1 ACCB Biotech Company Detail
11.6.2 ACCB Biotech Business Overview
11.6.3 ACCB Biotech PD-L1 and PIK3CA Testing Introduction
11.6.4 ACCB Biotech Revenue in PD-L1 and PIK3CA Testing Business (2017-2022)
11.6.5 ACCB Biotech Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global PD-L1 and PIK3CA Testing Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global PD-L1 and PIK3CA Testing Revenue Market Share by Type (2018-2023)
Table 7. Global PD-L1 and PIK3CA Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global PD-L1 and PIK3CA Testing Revenue Market Share by Type (2024-2029)
Table 9. Global PD-L1 and PIK3CA Testing Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global PD-L1 and PIK3CA Testing Revenue Market Share by Application (2018-2023)
Table 11. Global PD-L1 and PIK3CA Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global PD-L1 and PIK3CA Testing Revenue Market Share by Application (2024-2029)
Table 13. Global PD-L1 and PIK3CA Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global PD-L1 and PIK3CA Testing Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global PD-L1 and PIK3CA Testing Market Share by Region (2018-2023)
Table 16. Global PD-L1 and PIK3CA Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global PD-L1 and PIK3CA Testing Market Share by Region (2024-2029)
Table 18. PD-L1 and PIK3CA Testing Market Trends
Table 19. PD-L1 and PIK3CA Testing Market Drivers
Table 20. PD-L1 and PIK3CA Testing Market Challenges
Table 21. PD-L1 and PIK3CA Testing Market Restraints
Table 22. Global Top PD-L1 and PIK3CA Testing Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global PD-L1 and PIK3CA Testing Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global PD-L1 and PIK3CA Testing Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of PD-L1 and PIK3CA Testing, Headquarters and Area Served
Table 26. Global PD-L1 and PIK3CA Testing Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global PD-L1 and PIK3CA Testing by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America PD-L1 and PIK3CA Testing Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America PD-L1 and PIK3CA Testing Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe PD-L1 and PIK3CA Testing Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe PD-L1 and PIK3CA Testing Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America PD-L1 and PIK3CA Testing Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America PD-L1 and PIK3CA Testing Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country (2024-2029) & (US$ Million)
Table 45. Agilent Technologies Company Detail
Table 46. Agilent Technologies Business Overview
Table 47. Agilent Technologies PD-L1 and PIK3CA Testing Product
Table 48. Agilent Technologies Revenue in PD-L1 and PIK3CA Testing Business (2017-2022) & (US$ Million)
Table 49. Agilent Technologies Recent Development
Table 50. Roche Company Detail
Table 51. Roche Business Overview
Table 52. Roche PD-L1 and PIK3CA Testing Product
Table 53. Roche Revenue in PD-L1 and PIK3CA Testing Business (2017-2022) & (US$ Million)
Table 54. Roche Recent Development
Table 55. QIAGEN Company Detail
Table 56. QIAGEN Business Overview
Table 57. QIAGEN PD-L1 and PIK3CA Testing Product
Table 58. QIAGEN Revenue in PD-L1 and PIK3CA Testing Business (2017-2022) & (US$ Million)
Table 59. QIAGEN Recent Development
Table 60. EntroGen Company Detail
Table 61. EntroGen Business Overview
Table 62. EntroGen PD-L1 and PIK3CA Testing Product
Table 63. EntroGen Revenue in PD-L1 and PIK3CA Testing Business (2017-2022) & (US$ Million)
Table 64. EntroGen Recent Development
Table 65. Amoy Diagnostics Company Detail
Table 66. Amoy Diagnostics Business Overview
Table 67. Amoy Diagnostics PD-L1 and PIK3CA Testing Product
Table 68. Amoy Diagnostics Revenue in PD-L1 and PIK3CA Testing Business (2017-2022) & (US$ Million)
Table 69. Amoy Diagnostics Recent Development
Table 70. ACCB Biotech Company Detail
Table 71. ACCB Biotech Business Overview
Table 72. ACCB Biotech PD-L1 and PIK3CA Testing Product
Table 73. ACCB Biotech Revenue in PD-L1 and PIK3CA Testing Business (2017-2022) & (US$ Million)
Table 74. ACCB Biotech Recent Development
Table 75. Agilent Technologies Company Information
Table 76. Agilent Technologies Business Overview
Table 77. Agilent Technologies PD-L1 and PIK3CA Testing Revenue in PD-L1 and PIK3CA Testing Business (2018-2023) & (US$ Million)
Table 78. Agilent Technologies Revenue in PD-L1 and PIK3CA Testing Business (2018-2023) & (US$ Million) Portfolio
Table 79. Agilent Technologies Recent Development
Table 80. Roche Company Information
Table 81. Roche Business Overview
Table 82. Roche PD-L1 and PIK3CA Testing Revenue in PD-L1 and PIK3CA Testing Business (2018-2023) & (US$ Million)
Table 83. Roche Revenue in PD-L1 and PIK3CA Testing Business (2018-2023) & (US$ Million) Portfolio
Table 84. Roche Recent Development
Table 85. QIAGEN Company Information
Table 86. QIAGEN Business Overview
Table 87. QIAGEN PD-L1 and PIK3CA Testing Revenue in PD-L1 and PIK3CA Testing Business (2018-2023) & (US$ Million)
Table 88. QIAGEN Revenue in PD-L1 and PIK3CA Testing Business (2018-2023) & (US$ Million) Portfolio
Table 89. QIAGEN Recent Development
Table 90. EntroGen Company Information
Table 91. EntroGen Business Overview
Table 92. EntroGen PD-L1 and PIK3CA Testing Revenue in PD-L1 and PIK3CA Testing Business (2018-2023) & (US$ Million)
Table 93. EntroGen Revenue in PD-L1 and PIK3CA Testing Business (2018-2023) & (US$ Million) Portfolio
Table 94. EntroGen Recent Development
Table 95. Amoy Diagnostics Company Information
Table 96. Amoy Diagnostics Business Overview
Table 97. Amoy Diagnostics PD-L1 and PIK3CA Testing Revenue in PD-L1 and PIK3CA Testing Business (2018-2023) & (US$ Million)
Table 98. Amoy Diagnostics Revenue in PD-L1 and PIK3CA Testing Business (2018-2023) & (US$ Million) Portfolio
Table 99. Amoy Diagnostics Recent Development
Table 100. ACCB Biotech Company Information
Table 101. ACCB Biotech Business Overview
Table 102. ACCB Biotech PD-L1 and PIK3CA Testing Revenue in PD-L1 and PIK3CA Testing Business (2018-2023) & (US$ Million)
Table 103. ACCB Biotech Revenue in PD-L1 and PIK3CA Testing Business (2018-2023) & (US$ Million) Portfolio
Table 104. ACCB Biotech Recent Development
Table 105. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global PD-L1 and PIK3CA Testing Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global PD-L1 and PIK3CA Testing Revenue Market Share by Type (2018-2023)
Table 7. Global PD-L1 and PIK3CA Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global PD-L1 and PIK3CA Testing Revenue Market Share by Type (2024-2029)
Table 9. Global PD-L1 and PIK3CA Testing Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global PD-L1 and PIK3CA Testing Revenue Market Share by Application (2018-2023)
Table 11. Global PD-L1 and PIK3CA Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global PD-L1 and PIK3CA Testing Revenue Market Share by Application (2024-2029)
Table 13. Global PD-L1 and PIK3CA Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global PD-L1 and PIK3CA Testing Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global PD-L1 and PIK3CA Testing Market Share by Region (2018-2023)
Table 16. Global PD-L1 and PIK3CA Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global PD-L1 and PIK3CA Testing Market Share by Region (2024-2029)
Table 18. PD-L1 and PIK3CA Testing Market Trends
Table 19. PD-L1 and PIK3CA Testing Market Drivers
Table 20. PD-L1 and PIK3CA Testing Market Challenges
Table 21. PD-L1 and PIK3CA Testing Market Restraints
Table 22. Global Top PD-L1 and PIK3CA Testing Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global PD-L1 and PIK3CA Testing Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global PD-L1 and PIK3CA Testing Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of PD-L1 and PIK3CA Testing, Headquarters and Area Served
Table 26. Global PD-L1 and PIK3CA Testing Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global PD-L1 and PIK3CA Testing by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America PD-L1 and PIK3CA Testing Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America PD-L1 and PIK3CA Testing Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe PD-L1 and PIK3CA Testing Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe PD-L1 and PIK3CA Testing Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America PD-L1 and PIK3CA Testing Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America PD-L1 and PIK3CA Testing Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country (2024-2029) & (US$ Million)
Table 45. Agilent Technologies Company Detail
Table 46. Agilent Technologies Business Overview
Table 47. Agilent Technologies PD-L1 and PIK3CA Testing Product
Table 48. Agilent Technologies Revenue in PD-L1 and PIK3CA Testing Business (2017-2022) & (US$ Million)
Table 49. Agilent Technologies Recent Development
Table 50. Roche Company Detail
Table 51. Roche Business Overview
Table 52. Roche PD-L1 and PIK3CA Testing Product
Table 53. Roche Revenue in PD-L1 and PIK3CA Testing Business (2017-2022) & (US$ Million)
Table 54. Roche Recent Development
Table 55. QIAGEN Company Detail
Table 56. QIAGEN Business Overview
Table 57. QIAGEN PD-L1 and PIK3CA Testing Product
Table 58. QIAGEN Revenue in PD-L1 and PIK3CA Testing Business (2017-2022) & (US$ Million)
Table 59. QIAGEN Recent Development
Table 60. EntroGen Company Detail
Table 61. EntroGen Business Overview
Table 62. EntroGen PD-L1 and PIK3CA Testing Product
Table 63. EntroGen Revenue in PD-L1 and PIK3CA Testing Business (2017-2022) & (US$ Million)
Table 64. EntroGen Recent Development
Table 65. Amoy Diagnostics Company Detail
Table 66. Amoy Diagnostics Business Overview
Table 67. Amoy Diagnostics PD-L1 and PIK3CA Testing Product
Table 68. Amoy Diagnostics Revenue in PD-L1 and PIK3CA Testing Business (2017-2022) & (US$ Million)
Table 69. Amoy Diagnostics Recent Development
Table 70. ACCB Biotech Company Detail
Table 71. ACCB Biotech Business Overview
Table 72. ACCB Biotech PD-L1 and PIK3CA Testing Product
Table 73. ACCB Biotech Revenue in PD-L1 and PIK3CA Testing Business (2017-2022) & (US$ Million)
Table 74. ACCB Biotech Recent Development
Table 75. Agilent Technologies Company Information
Table 76. Agilent Technologies Business Overview
Table 77. Agilent Technologies PD-L1 and PIK3CA Testing Revenue in PD-L1 and PIK3CA Testing Business (2018-2023) & (US$ Million)
Table 78. Agilent Technologies Revenue in PD-L1 and PIK3CA Testing Business (2018-2023) & (US$ Million) Portfolio
Table 79. Agilent Technologies Recent Development
Table 80. Roche Company Information
Table 81. Roche Business Overview
Table 82. Roche PD-L1 and PIK3CA Testing Revenue in PD-L1 and PIK3CA Testing Business (2018-2023) & (US$ Million)
Table 83. Roche Revenue in PD-L1 and PIK3CA Testing Business (2018-2023) & (US$ Million) Portfolio
Table 84. Roche Recent Development
Table 85. QIAGEN Company Information
Table 86. QIAGEN Business Overview
Table 87. QIAGEN PD-L1 and PIK3CA Testing Revenue in PD-L1 and PIK3CA Testing Business (2018-2023) & (US$ Million)
Table 88. QIAGEN Revenue in PD-L1 and PIK3CA Testing Business (2018-2023) & (US$ Million) Portfolio
Table 89. QIAGEN Recent Development
Table 90. EntroGen Company Information
Table 91. EntroGen Business Overview
Table 92. EntroGen PD-L1 and PIK3CA Testing Revenue in PD-L1 and PIK3CA Testing Business (2018-2023) & (US$ Million)
Table 93. EntroGen Revenue in PD-L1 and PIK3CA Testing Business (2018-2023) & (US$ Million) Portfolio
Table 94. EntroGen Recent Development
Table 95. Amoy Diagnostics Company Information
Table 96. Amoy Diagnostics Business Overview
Table 97. Amoy Diagnostics PD-L1 and PIK3CA Testing Revenue in PD-L1 and PIK3CA Testing Business (2018-2023) & (US$ Million)
Table 98. Amoy Diagnostics Revenue in PD-L1 and PIK3CA Testing Business (2018-2023) & (US$ Million) Portfolio
Table 99. Amoy Diagnostics Recent Development
Table 100. ACCB Biotech Company Information
Table 101. ACCB Biotech Business Overview
Table 102. ACCB Biotech PD-L1 and PIK3CA Testing Revenue in PD-L1 and PIK3CA Testing Business (2018-2023) & (US$ Million)
Table 103. ACCB Biotech Revenue in PD-L1 and PIK3CA Testing Business (2018-2023) & (US$ Million) Portfolio
Table 104. ACCB Biotech Recent Development
Table 105. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. PD-L1 and PIK3CA Testing Product Picture
Figure 5. Global PD-L1 and PIK3CA Testing Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global PD-L1 and PIK3CA Testing Market Share by Type: 2022 VS 2029
Figure 7. PD-L1 Testing Product Picture
Figure 8. PIK3CA Testing Product Picture
Figure 9. Global PD-L1 and PIK3CA Testing Market Size by Application (2023-2029) & (US$ Million)
Figure 10. Global PD-L1 and PIK3CA Testing Market Share by Application: 2022 VS 2029
Figure 11. Hospital Product Picture
Figure 12. Diagnostic Center Product Picture
Figure 13. Others Product Picture
Figure 14. Global PD-L1 and PIK3CA Testing Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global PD-L1 and PIK3CA Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global PD-L1 and PIK3CA Testing Market Share by Region: 2022 VS 2029
Figure 17. Global PD-L1 and PIK3CA Testing Market Share by Players in 2022
Figure 18. Global PD-L1 and PIK3CA Testing Players, Date of Enter into This Industry
Figure 19. Global Top 5 and 10 PD-L1 and PIK3CA Testing Players Market Share by Revenue in 2022
Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 21. North America PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America PD-L1 and PIK3CA Testing Market Share by Country (2018-2029)
Figure 23. United States PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe PD-L1 and PIK3CA Testing Market Share by Country (2018-2029)
Figure 27. Germany PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific PD-L1 and PIK3CA Testing Market Share by Country (2018-2029)
Figure 35. China PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America PD-L1 and PIK3CA Testing Market Share by Country (2018-2029)
Figure 43. Mexico PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa PD-L1 and PIK3CA Testing Market Share by Country (2018-2029)
Figure 47. Turkey PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. UAE PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Agilent Technologies Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2018-2023)
Figure 51. Roche Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2018-2023)
Figure 52. QIAGEN Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2018-2023)
Figure 53. EntroGen Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2018-2023)
Figure 54. Amoy Diagnostics Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2018-2023)
Figure 55. ACCB Biotech Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2018-2023)
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. PD-L1 and PIK3CA Testing Product Picture
Figure 5. Global PD-L1 and PIK3CA Testing Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global PD-L1 and PIK3CA Testing Market Share by Type: 2022 VS 2029
Figure 7. PD-L1 Testing Product Picture
Figure 8. PIK3CA Testing Product Picture
Figure 9. Global PD-L1 and PIK3CA Testing Market Size by Application (2023-2029) & (US$ Million)
Figure 10. Global PD-L1 and PIK3CA Testing Market Share by Application: 2022 VS 2029
Figure 11. Hospital Product Picture
Figure 12. Diagnostic Center Product Picture
Figure 13. Others Product Picture
Figure 14. Global PD-L1 and PIK3CA Testing Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global PD-L1 and PIK3CA Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global PD-L1 and PIK3CA Testing Market Share by Region: 2022 VS 2029
Figure 17. Global PD-L1 and PIK3CA Testing Market Share by Players in 2022
Figure 18. Global PD-L1 and PIK3CA Testing Players, Date of Enter into This Industry
Figure 19. Global Top 5 and 10 PD-L1 and PIK3CA Testing Players Market Share by Revenue in 2022
Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 21. North America PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America PD-L1 and PIK3CA Testing Market Share by Country (2018-2029)
Figure 23. United States PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe PD-L1 and PIK3CA Testing Market Share by Country (2018-2029)
Figure 27. Germany PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific PD-L1 and PIK3CA Testing Market Share by Country (2018-2029)
Figure 35. China PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America PD-L1 and PIK3CA Testing Market Share by Country (2018-2029)
Figure 43. Mexico PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa PD-L1 and PIK3CA Testing Market Share by Country (2018-2029)
Figure 47. Turkey PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. UAE PD-L1 and PIK3CA Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Agilent Technologies Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2018-2023)
Figure 51. Roche Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2018-2023)
Figure 52. QIAGEN Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2018-2023)
Figure 53. EntroGen Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2018-2023)
Figure 54. Amoy Diagnostics Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2018-2023)
Figure 55. ACCB Biotech Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2018-2023)
